CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.9000
-0.1200 (-11.76%)
At close: Jan 30, 2026, 4:00 PM EST
0.8601
-0.0399 (-4.43%)
After-hours: Jan 30, 2026, 7:59 PM EST
CalciMedica Market Cap
CalciMedica has a market cap or net worth of $12.97 million as of January 30, 2026. Its market cap has decreased by -68.15% in one year.
Market Cap
12.97M
Enterprise Value
7.78M
1-Year Change
-68.15%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since March 21, 2023, CalciMedica's market cap has decreased from $18.50M to $12.97M, a decrease of -29.89%. That is a compound annual growth rate of -11.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 12.97M | -86.34% |
| Dec 31, 2025 | 94.96M | 98.97% |
| Dec 31, 2024 | 47.73M | 193.54% |
| Dec 29, 2023 | 16.26M | -12.10% |
| Mar 21, 2023 | 18.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 13.83M |
| Hoth Therapeutics | 13.78M |
| Cellectar Biosciences | 13.65M |
| Cocrystal Pharma | 13.51M |
| Tempest Therapeutics | 13.40M |
| Moleculin Biotech | 13.21M |
| BioCardia | 13.05M |
| BioLineRx | 12.64M |